These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29061750)

  • 21. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
    Baroud M; Dandache I; Araj GF; Wakim R; Kanj S; Kanafani Z; Khairallah M; Sabra A; Shehab M; Dbaibo G; Matar GM
    Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced Susceptibility to Cefepime in Clinical Isolates of Enterobacteriaceae Producing OXA-1 Beta-Lactamase.
    Torres E; López-Cerero L; Rodríguez-Martínez JM; Pascual Á
    Microb Drug Resist; 2016 Mar; 22(2):141-6. PubMed ID: 26295796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CTX-M-15-Producing Shewanella Species Clinical Isolate Expressing OXA-535, a Chromosome-Encoded OXA-48 Variant, Putative Progenitor of the Plasmid-Encoded OXA-436.
    Jousset AB; Dabos L; Bonnin RA; Girlich D; Potron A; Cabanel N; Dortet L; Glaser P; Naas T
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038283
    [No Abstract]   [Full Text] [Related]  

  • 24. Characterization of Carbapenemase-Producing Enterobacteriaceae from Patients in Amman, Jordan.
    Aqel AA; Findlay J; Al-Maayteh M; Al-Kaabneh A; Hopkins KL; Alzoubi H; Masalha I; Turton J; Woodford N; Ellington MJ
    Microb Drug Resist; 2018 Oct; 24(8):1121-1127. PubMed ID: 29653473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A single-day point-prevalence study of faecal carriers in long-term care hospitals in Madrid (Spain) depicts a complex clonal and polyclonal dissemination of carbapenemase-producing Enterobacteriaceae.
    Ruiz-Garbajosa P; Hernández-García M; Beatobe L; Tato M; Méndez MI; Grandal M; Aranzábal L; Alonso S; Lópaz MÁ; Astray J; Cantón R
    J Antimicrob Chemother; 2016 Feb; 71(2):348-52. PubMed ID: 26518051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Countrywide spread of OXA-48 carbapenemase in Lebanon: surveillance and genetic characterization of carbapenem-non-susceptible Enterobacteriaceae in 10 hospitals over a one-year period.
    Hammoudi D; Ayoub Moubareck C; Aires J; Adaime A; Barakat A; Fayad N; Hakime N; Houmani M; Itani T; Najjar Z; Suleiman M; Sarraf R; Karam Sarkis D
    Int J Infect Dis; 2014 Dec; 29():139-44. PubMed ID: 25449248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotypic and genotypic characteristics of carbapenem-resistant Enterobacteriaceae in a tertiary-level reference hospital in Turkey.
    Baran I; Aksu N
    Ann Clin Microbiol Antimicrob; 2016 Apr; 15():20. PubMed ID: 27048322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Environmental Spread of New Delhi Metallo-β-Lactamase-1-Producing Multidrug-Resistant Bacteria in Dhaka, Bangladesh.
    Islam MA; Islam M; Hasan R; Hossain MI; Nabi A; Rahman M; Goessens WHF; Endtz HP; Boehm AB; Faruque SM
    Appl Environ Microbiol; 2017 Aug; 83(15):. PubMed ID: 28526792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel OXA-10-like beta-lactamase is present in different Enterobacteriaceae.
    Porto A; Ayala J; Gutkind G; Di Conza J
    Diagn Microbiol Infect Dis; 2010 Feb; 66(2):228-9. PubMed ID: 19833470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterogeneous hydrolytic features for OXA-48-like β-lactamases.
    Oueslati S; Nordmann P; Poirel L
    J Antimicrob Chemother; 2015 Apr; 70(4):1059-63. PubMed ID: 25583748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D β-lactamases.
    Mushtaq S; Vickers A; Woodford N; Livermore DM
    J Antimicrob Chemother; 2017 Jun; 72(6):1688-1695. PubMed ID: 28333319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and biochemical characterisation of OXA-232, a carbapenem-hydrolysing class D β-lactamase from Enterobacteriaceae.
    Potron A; Rondinaud E; Poirel L; Belmonte O; Boyer S; Camiade S; Nordmann P
    Int J Antimicrob Agents; 2013 Apr; 41(4):325-9. PubMed ID: 23305656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and Molecular Characteristics of Carbapenemase-Producing Enterobacteriaceae From Five Hospitals in Korea.
    Jeong SH; Kim HS; Kim JS; Shin DH; Kim HS; Park MJ; Shin S; Hong JS; Lee SS; Song W
    Ann Lab Med; 2016 Nov; 36(6):529-35. PubMed ID: 27578505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and mechanisms of resistance to carbapenems in Enterobacteriaceae isolates from 24 hospitals in Belgium.
    Huang TD; Berhin C; Bogaerts P; Glupczynski Y;
    J Antimicrob Chemother; 2013 Aug; 68(8):1832-7. PubMed ID: 23557926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissemination of IncFII(K)-type plasmids in multiresistant CTX-M-15-producing Enterobacteriaceae isolates from children in hospital paediatric oncology wards.
    Dolejska M; Brhelova E; Dobiasova H; Krivdova J; Jurankova J; Sevcikova A; Dubska L; Literak I; Cizek A; Vavrina M; Kutnikova L; Sterba J
    Int J Antimicrob Agents; 2012 Dec; 40(6):510-5. PubMed ID: 23043911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae from Bangkok, Thailand, and Their Detection by the Carba NP and Modified Carbapenem Inactivation Method Tests.
    Laolerd W; Akeda Y; Preeyanon L; Ratthawongjirakul P; Santanirand P
    Microb Drug Resist; 2018 Sep; 24(7):1006-1011. PubMed ID: 29782216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: toward endemicity?
    Tato M; Coque TM; Ruíz-Garbajosa P; Pintado V; Cobo J; Sader HS; Jones RN; Baquero F; Cantón R
    Clin Infect Dis; 2007 Nov; 45(9):1171-8. PubMed ID: 17918078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline.
    Livermore DM; Warner M; Mushtaq S; Doumith M; Zhang J; Woodford N
    Int J Antimicrob Agents; 2011 May; 37(5):415-9. PubMed ID: 21429716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the First OXA-10 Natural Variant with Increased Carbapenemase Activity.
    Kotsakis SD; Flach CF; Razavi M; Larsson DGJ
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of ESBL- and AmpC-Producing Enterobacteriaceae from Diseased Companion Animals in Europe.
    Bogaerts P; Huang TD; Bouchahrouf W; Bauraing C; Berhin C; El Garch F; Glupczynski Y;
    Microb Drug Resist; 2015 Dec; 21(6):643-50. PubMed ID: 26098354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.